Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mircera in Peritoneal Dialysis Patients Previously Treated with ESA
NCT01807481Phase 4Unknown
- Sponsor
- Samsung Medical Center
- Start
- Mar 2013
- Primary completion
- Feb 2015
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 4 trial of Epoetin alfa RB in anemia of chronic kidney disease (CKD-A), sponsored by Samsung Medical Center. Status: unknown.
02
Drugs
Epoetin alfa RB
03
Conditions
anemia of chronic kidney disease (CKD-A)
Beyond the preview
Go deeper on NCT01807481.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01807481.